8-KThe WireStrategic
Equity Issuance · Bylaw Amendment
Filed Nov 17, 2022 · 3y ago · Accession 0001193125-22-287727
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Nov 17, 2022
- Report date
- Nov 14, 2022
- Document
- d410573d8k.htm
- Size
- 217 KB